NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1032230550

Registered date:10/01/2024

Super Lizer use in AV fistula creation

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedEnd-stage kidney disease; hemodialysis
Date of first enrollment24/01/2024
Target sample size10
Countries of recruitment
Study typeInterventional
Intervention(s)1. The researchers explain the study to the patient and obtain informed consent during the preoperative outpatient visit. Fistula creation site, either in the forearm or the upper arm, is determined and recorded. 2. On the day of surgery, the surgeons, in the operating room use ultrasound to measure the pre-intervention vessel diameter and blood flow with the use of tourniquet on the planned fistula creation site. The measurement data and ultrasound images are recorded. 3. Immediately prior to the surgery, the anesthesiologist performs stellate ganglion irradiation: (a) The SuperLizer PX linearly polarized near-infrared therapeutic device (Tokyo Iken CO., LTD)'s SG tip unit is placed near the cervical stellate ganglion. (b) Irradiation is performed in fixed mode (output: 80%, duration: 3 minutes). 4. After stellate ganglion irradiation, during surgical preparation, the surgeons measures the vessel diameter and blood flow with the use of tourniquet on the fistula creation site. The measurement data and ultrasound images, are recorded, and the final decision on the fistula creation site will be made. 5. Hemodialysis AV fistula creation is performed under local anesthesia.

Outcome(s)

Primary OutcomeThe difference/change rate in vein diameter with the use of tourniquet before and after stellate ganglion light irradiation (mm/%): A) Creation site in the forearm: Cephalic vein at the wrist. B) Creation site in the upper arm: Cephalic vein at the elbow.
Secondary Outcome1. The difference/change rate in arterial vessel diameter before and after stellate ganglion light irradiation (mm/%): A) Creation site in the forearm: Radial artery at the wrist. B) Creation site in the upper arm: Radial artery at the elbow. C) Creation site in the upper arm using the brachial artery (upstream of the radial artery): Brachial artery. 2. The blood flow in the brachial artery immediately after surgery. 3. The pain VAS (Visual Analogue Scale) immediately after surgery. 4. Surgical duration. 5. The change of the planned fistula creation site from upper arm to forearm. 6. The fistula patency rate at 1 month: Confirmed by fistula sound, thrill, and ultrasound.

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteria1. Patients who are scheduled for arteriovenous fistula creation for hemodialysis. 2. Patients who have a sufficient understanding of the research and provide consent. 3. Patients who are 18 years of age or older at the time of obtaining consent.
Exclude criteria1. Patients with arterial vessel diameter at the planned arteriovenous fistula site of 1.5mm or less. 2. Patients with venous vessel diameter at the planned arteriovenous fistula site of 2mm or less after tourniquet 3. Patients with significant arterial sclerosis at the planned arteriovenous fistula site. 4. Patients with glaucoma. 5. Patients with cataracts. 6. Patients with BMI >= 35. 7. Patients with skin disorders at the planned irradiation site. 8. Patients who are considered unsuitable for participation in this study by the attending physician.

Related Information

Contact

Public contact
Name Zhuan Jin
Address 929, Higashi-cho, Kamogawa city, Chiba Prefecture Chiba Japan 296-0041
Telephone +81-4-7092-2211
E-mail jin.zhuan@kameda.jp
Affiliation Kameda Medical Center
Scientific contact
Name Daisuke Sugiyama
Address 929, Higashi-cho, Kamogawa city, Chiba Prefecture Chiba Japan 296-0041
Telephone +81-4-7092-2211
E-mail sugiyama.daisuke@kameda.jp
Affiliation Kameda Medical Center